2 years ago
NVAX
AnalystsAlec StranahanAlec Stranahan's Stock Forecasts
AnalystsAlec Stranahan
Sectors:
Industries:
Analyst Ranking
Bottom 1%
#5275 out of 5296 analysts
Average Return
-43.88%
Win Rate
34%10 out of 29
Risk vs Reward
Poor
Good
Alec Stranahan's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Krystal Biotech IncKRYS | +113.79% | $151.90 | $324.75 | 2025-07-21 - 2026-06-15 | Strong Buy |
Turning Point Therapeutics IncTPTX | +106.89% | $36.74 | $76.01 | 2022-05-19 - 2022-08-16 | Strong Buy |
Krystal Biotech IncKRYS | +70.71% | $190.23 | $324.75 | 2025-10-16 - 2026-06-15 | Strong Buy |
Revolution Medicines IncRVMD | +55.46% | $28.38 | $44.12 | 2024-01-04 - 2025-01-03 | Strong Buy |
Krystal Biotech IncKRYS | +41.95% | $117.53 | $166.83 | 2023-05-21 - 2024-05-21 | Strong Buy |
Alec Stranahan Analyst Color
Get additional color on Alec Stranahan's coverage of popular stocks
2 years ago
NVAX
Alec Stranahan's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Avalo Therapeutics IncAVTX | 1 | Strong Buy | $35.00 | +139.73% | Initiates Coverage On | 5 days ago |
Erasca IncERAS | 4 | Hold | $16.00 | +10.88% | Upgrades | 13 days ago |
Wave Life Sciences LtdWVE | 1 | Strong Buy | $21.00 | +250.00% | Maintains | 3 months ago |
Krystal Biotech IncKRYS | 6 | Strong Buy | $318.00 | -2.08% | Maintains | 5 months ago |
Candel Therapeutics IncCADL | 2 | Hold | $7.00 | -18.22% | Downgrades | 9 months ago |
Xencor IncXNCR | 2 | Hold | $12.00 | -1.72% | Downgrades | 9 months ago |
Novavax IncNVAX | 4 | Sell | $7.00 | -24.00% | Downgrades | 10 months ago |
Beam Therapeutics IncBEAM | 1 | Strong Buy | $42.00 | N/A | Upgrades | a year ago |
Y Mabs Therapeutics IncYMAB | 5 | Hold | $12.00 | N/A | Maintains | a year ago |
Day One Biopharmaceuticals IncDAWN | 5 | Strong Buy | $25.00 | N/A | Maintains | a year ago |
Caribou Biosciences IncCRBU | 1 | Strong Buy | $11.00 | N/A | Maintains | a year ago |
Perspective Therapeutics IncCATX | 2 | Hold | $6.00 | N/A | Downgrades | 2 years ago |
Editas Medicine IncEDIT | 1 | Strong Buy | $15.00 | N/A | Upgrades | 2 years ago |
Revolution Medicines IncRVMD | 3 | Strong Buy | $55.00 | N/A | Maintains | 2 years ago |
Tg Therapeutics IncTGTX | 2 | Sell | $6.00 | N/A | Maintains | 3 years ago |
Hookipa Pharma IncHOOK | 1 | Sell | $5.00 | N/A | Downgrades | 4 years ago |
Springworks Therapeutics IncSWTX | 1 | Strong Buy | $45.00 | N/A | Initiates Coverage On | 4 years ago |
Turning Point Therapeutics IncTPTX | 1 | Strong Buy | $58.00 | N/A | Initiates Coverage On | 4 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.